venBio Partners as of June 30, 2021
Portfolio Holdings for venBio Partners
venBio Partners holds 10 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alx Oncology Hldgs (ALXO) | 62.6 | $530M | 9.7M | 54.68 | |
| Harmony Biosciences Hldgs In (HRMY) | 11.7 | $99M | 3.5M | 28.23 | |
| Akero Therapeutics (AKRO) | 6.4 | $55M | 2.2M | 24.81 | |
| Pharvaris N V (PHVS) | 5.1 | $43M | 2.3M | 18.63 | |
| Elevation Oncology (ELEV) | 4.2 | $35M | 2.6M | 13.57 | |
| Apellis Pharmaceuticals (APLS) | 3.1 | $26M | 412k | 63.20 | |
| Impel Neuropharma (IMPLQ) | 2.9 | $24M | 2.8M | 8.85 | |
| Checkmate Pharmaceuticals In | 2.6 | $22M | 3.7M | 5.96 | |
| Metacrine Ord | 1.4 | $12M | 3.1M | 3.80 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.1 | $1.1M | 162k | 6.54 |
